13G Filing: Iroquois Capital Management, LLC and Apricus Biosciences Inc. (APRI)

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

(5)

Sole Voting Power
242,761 shares of Common Stock
107,142 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*

(6)

Shared Voting Power
415,441 shares of Common Stock
214,287 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*

(7)

Sole Dispositive Power
242,761 shares of Common Stock
107,142 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*

(8)

Shared Dispositive Power
415,441 shares of Common Stock
214,287 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*

CUSIP No: 03832V307
	(1)	Names of Reporting Persons Richard Abbe
	(2)	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)	o
		(b)	o

	(3)	SEC Use Only

	(4)	Citizenship or Place of Organization United States of America

	(9)	Aggregate Amount Beneficially Owned by Each Reporting Person 658,202 shares of Common Stock 321,429 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*

	(10)	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	(11)	Percent of Class Represented by Amount in Row (9) 5.2%

	(12)	Type of Reporting Person (See Instructions) IN; HC

Page 3 of 7 – SEC Filing